Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad?

• Published in: Journal of the American College of Cardiology Vol. 70; no. 6; p. 756
• Main Authors: Guichard, Jean-Baptiste, Nattel, Stanley
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 08.08.2017
• Subjects: Arrhythmia; Cardiac arrhythmia; Cardiology; Cardiomyopathies - therapy; Cardiomyopathy; Catheter Ablation - methods; Catheters; Clinical trials; Disease Management; Fibrillation; Heart; Heart Atria; Heart failure; Humans; Sleep; Sleep apnea; Stroke; Terminology; Thromboembolism; atrial fibrillation; electrophysiology; arrhythmia therapy; stroke; heart disease treatment; ablation
• ISSN: 0735-1097; 1558-3597; 1558-3597
• DOI: 10.1016/j.jacc.2017.06.033

The term atrial cardiomyopathy, which has been used sporadically in the medical literature, was recently the subject of a detailed Consensus Document prepared by representatives of the European Heart Rhythm Association, Heart Rhythm Society, Asia-Pacific Heart Rhythm Society, and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiología. They discussed aspects of the definition, histopathology, atrial-specific physiology, atrial pathology, impact on arrhythmia occurrence, imaging, mapping, and ablation. Here, the authors consider critically the added clinical value of this concept and its meaningfulness. They review evidence implicating atrial cardiomyopathy as an independent contributor to the risk of stroke associated with atrial fibrillation and as a determinant of arrhythmia progression. The issue of classification is considered and the authors discuss how atrial cardiomyopathic properties might guide stroke prevention, rhythm maintenance, and rate control in atrial fibrillation. Carefully designed clinical trials are needed to evaluate these potential applications, and will ultimately define the value of this terminology.